Medeiros, Gabriela A <br/><br/>
Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage.  [electronic resource] 

 -  Microbes and infection  Feb 2009 
 - 264-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1769-714X 
<br/><br/><label>Standard No.: </label>10.1016/j.micinf.2008.11.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CCR5 Receptor Antagonists<br/>CD4-Positive T-Lymphocytes--immunology<br/>Chagas Cardiomyopathy--drug therapy<br/>Chagas Disease--drug therapy<br/>Chemokine CCL5--pharmacology<br/>Connexin 43--analysis<br/>Female<br/>Heart--parasitology<br/>Immunologic Factors--pharmacology<br/>Interleukin-10--biosynthesis<br/>Interleukin-13--biosynthesis<br/>Mice<br/>Mice, Inbred C3H<br/>Myocardium--chemistry<br/>Receptors, CCR1--antagonists & inhibitors<br/>Trypanosoma cruzi--physiology<br/>Tumor Necrosis Factor-alpha--biosynthesis